Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice.
Ando Y, Kawaoka T, Kosaka M, Shirane Y, Johira Y, Miura R, Murakami S, Yano S, Amioka K, Naruto K, Kosaka Y, Uchikawa S, Kodama K, Fujino H, Nakahara T, Ono A, Murakami E, Yamauchi M, Okamoto W, Takahashi S, Imamura M, Chayama K, Aikata H.
Ando Y, et al. Among authors: takahashi s.
Cancers (Basel). 2021 Aug 5;13(16):3958. doi: 10.3390/cancers13163958.
Cancers (Basel). 2021.
PMID: 34439111
Free PMC article.